Skip to main content
. Author manuscript; available in PMC: 2014 Jun 11.
Published in final edited form as: Biol Blood Marrow Transplant. 2012 Dec 7;19(3):474–480. doi: 10.1016/j.bbmt.2012.12.001

Table 4.

Summary of Bayesian Logistic Regression Model for TRM by Day 100, RFS and OS

Day-100 NRM RFS OS
Variable Mean SD 95% CI Pr (Harmful Effect) Mean SD 95% CI Pr (Beneficial Effect) Mean SD 95% CI Pr (Beneficial Effect)
Intercept −3.042 0.918 −1.033 0.359 −0.637 0.327
Age 0.126 0.062 0.021, 0.265 0.992 −0.012 0.015 −0.042, 0.017 0.198 −0.025 0.014 −0.052, 0.017 0.035
Cytogenetics Bad (vs. Intermediate) 0.739 0.872 −1.055, 2.388 0.812 −0.924 0.401 −1.722, −0.143 0.011 −0.667 0.370 −1.380, 0.063 0.035
Cytogenetics Good (vs. Intermediate) −1.845 2.292 −6.560, 2.022 0.221 1.234 0.726 −0.214, 2.678 0.954 1.105 0.662 −0.185, 2.406 0.953
Cytogenetics Unknown (vs. Intermediate) 0.471 1.398 −2.541, 2.916 0.662 −0.330 0.645 −1.585, 0.917 0.307 −0.326 0.592 −1.474, 0.825 0.293
Log (Number of Blasts) −0.138 0.215 −0.550, 0.283 0.252 −0.173 0.091 −0.348, 0.005 0.027 −0.113 0.084 −0.274, 0.057 0.092
Dose level 5 (vs. all other levels) −0.361 0.907 −2.127, 1.471 0.337 0.801 0.412 −0.014, 1.608 0.973 0.761 0.378 0.015, 1.487 0.977

NRM: non relapse mortality; RFS: relapse free survival; OS: overall survival